Tumor cells can increase lipid metabolism by enhancing endogenous lipid de novo synthesis pathway and exogenous lipid uptake, including the overexpression of FASN, ACC1, HMGCR, CD36, FABP and LDLR. This evidence concerns the gene HMGCR and neoplasm.